BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21734159)

  • 1. Real-time FDG PET guidance during biopsies and radiofrequency ablation using multimodality fusion with electromagnetic navigation.
    Venkatesan AM; Kadoury S; Abi-Jaoudeh N; Levy EB; Maass-Moreno R; Krücker J; Dalal S; Xu S; Glossop N; Wood BJ
    Radiology; 2011 Sep; 260(3):848-56. PubMed ID: 21734159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of real-time fusion guidance for biopsy and ablation.
    Krücker J; Xu S; Venkatesan A; Locklin JK; Amalou H; Glossop N; Wood BJ
    J Vasc Interv Radiol; 2011 Apr; 22(4):515-24. PubMed ID: 21354816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electromagnetic tracking for thermal ablation and biopsy guidance: clinical evaluation of spatial accuracy.
    Krücker J; Xu S; Glossop N; Viswanathan A; Borgert J; Schulz H; Wood BJ
    J Vasc Interv Radiol; 2007 Sep; 18(9):1141-50. PubMed ID: 17804777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/CT-guided radiofrequency and cryoablation: is tumor fluorine-18 fluorodeoxyglucose activity dissipated by thermal ablation?
    Sainani NI; Shyn PB; Tatli S; Morrison PR; Tuncali K; Silverman SG
    J Vasc Interv Radiol; 2011 Mar; 22(3):354-60. PubMed ID: 21353987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of FDG PET/CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation.
    Deandreis D; Leboulleux S; Dromain C; Auperin A; Coulot J; Lumbroso J; Deschamps F; Rao P; Schlumberger M; de Baère T
    Radiology; 2011 Jan; 258(1):270-6. PubMed ID: 21045185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-Time US-
    Mauri G; Gennaro N; De Beni S; Ierace T; Goldberg SN; Rodari M; Solbiati LA
    Cardiovasc Intervent Radiol; 2019 Jan; 42(1):60-68. PubMed ID: 30288593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness.
    Ryan ER; Sofocleous CT; Schöder H; Carrasquillo JA; Nehmeh S; Larson SM; Thornton R; Siegelbaum RH; Erinjeri JP; Solomon SB
    Radiology; 2013 Jul; 268(1):288-95. PubMed ID: 23564714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting liver lesions for radiofrequency ablation: an experimental feasibility study using a CT-US fusion imaging system.
    Crocetti L; Lencioni R; Debeni S; See TC; Pina CD; Bartolozzi C
    Invest Radiol; 2008 Jan; 43(1):33-9. PubMed ID: 18097275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of in situ, high-resolution correlation of tracer uptake with histopathology by quantitative autoradiography of biopsy specimens obtained under 18F-FDG PET/CT guidance.
    Fanchon LM; Dogan S; Moreira AL; Carlin SA; Schmidtlein CR; Yorke E; Apte AP; Burger IA; Durack JC; Erinjeri JP; Maybody M; Schöder H; Siegelbaum RH; Sofocleous CT; Deasy JO; Solomon SB; Humm JL; Kirov AS
    J Nucl Med; 2015 Apr; 56(4):538-44. PubMed ID: 25722446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation of non-small-cell carcinoma of the lung under real-time FDG PET CT guidance.
    Schoellnast H; Larson SM; Nehmeh SA; Carrasquillo JA; Thornton RH; Solomon SB
    Cardiovasc Intervent Radiol; 2011 Feb; 34 Suppl 2():S182-5. PubMed ID: 20508937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results.
    Okuma T; Okamura T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Koyama K; Inoue K; Nakamura K; Inoue Y
    Ann Nucl Med; 2006 Feb; 20(2):115-21. PubMed ID: 16615420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraprocedural Ablation Margin Assessment by Using Ammonia Perfusion PET during FDG PET/CT-guided Liver Tumor Ablation: A Pilot Study.
    Shyn PB; Casadaban LC; Sainani NI; Sadow CA; Bunch PM; Levesque VM; Kim CK; Gerbaudo VH; Silverman SG
    Radiology; 2018 Jul; 288(1):138-145. PubMed ID: 29613843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET/CT-directed biopsy: does it offer incremental benefit?
    Purandare NC; Kulkarni AV; Kulkarni SS; Roy D; Agrawal A; Shah S; Rangarajan V
    Nucl Med Commun; 2013 Mar; 34(3):203-10. PubMed ID: 23353885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
    Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
    Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET/CT-guided percutaneous liver mass biopsies and ablations: targeting accuracy of a single 20 s breath-hold PET acquisition.
    Shyn PB; Tatli S; Sahni VA; Sadow CA; Forgione K; Mauri G; Morrison PR; Catalano PJ; Silverman SG
    Clin Radiol; 2014 Apr; 69(4):410-5. PubMed ID: 24411824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cone-beam computed tomography fusion and navigation for real-time positron emission tomography-guided biopsies and ablations: a feasibility study.
    Abi-Jaoudeh N; Mielekamp P; Noordhoek N; Venkatesan AM; Millo C; Radaelli A; Carelsen B; Wood BJ
    J Vasc Interv Radiol; 2012 Jun; 23(6):737-43. PubMed ID: 22494658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
    Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
    Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
    Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
    J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of whole-body imaging on treatment decision to radio-frequency ablation in patients with malignant liver tumors: comparison of [18F]fluorodeoxyglucose-PET/computed tomography, PET and computed tomography.
    Kuehl H; Rosenbaum-Krumme S; Veit-Haibach P; Stergar H; Forsting M; Bockisch A; Antoch G
    Nucl Med Commun; 2008 Jul; 29(7):599-606. PubMed ID: 18528181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective comparison between auto-registration and manual registration of real-time ultrasound with MR images for percutaneous ablation or biopsy of hepatic lesions.
    Cha DI; Lee MW; Song KD; Oh YT; Jeong JY; Chang JW; Ryu J; Lee KJ; Kim J; Bang WC; Shin DK; Choi SJ; Koh D; Seo BK; Kim K
    Abdom Radiol (NY); 2017 Jun; 42(6):1799-1808. PubMed ID: 28194514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.